Product Information
RINVOQ ER 45 MG TABLET is a brand product labeled by AbbVie Inc., priced at $458.5378 per EA under NDC 00074104328. Its NADAC has been published 110 times since May 22, 2024.
Strength
45 mg/1
Manufacturer
AbbVie Inc.NDC
00074104328
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
UPADACITINIBApproval Type
New Drug (NDA)
FDA Application
NDA211675On Market Since
8/16/2019
Pharmacological Classes
Price Statistics
The NADAC for RINVOQ ER 45 MG TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has risen 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $458.5378 per EA |
|---|---|
| All-time high | $460.0432 (May 13, 2026) |
| All-time low | $414.8360 (Jul 17, 2024) |
| 52-week high | $460.0432 |
| 52-week low | $436.5521 |
| Median price | $436.6304 |
| Average price | $435.5543 |
| Largest weekly change | +5.0% (Jan 8, 2025) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Upadacitinib market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RINVOQ ER 45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RINVOQ ER 45 MG TABLET, manufactured by AbbVie Inc., is $458.5378 per EA (NDC 00074104328), effective Jun 24, 2026.
How has the price of RINVOQ ER 45 MG TABLET changed over time?
Over the history we have for it, the NADAC for RINVOQ ER 45 MG TABLET has risen 10.2%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for RINVOQ ER 45 MG TABLET?
Since May 22, 2024, the NADAC for RINVOQ ER 45 MG TABLET has ranged from a low of $414.8360 (Jul 17, 2024) to a high of $460.0432 (May 13, 2026), with a median of $436.6304 per EA.
Are there cheaper alternatives to RINVOQ ER 45 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RINVOQ ER 45 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures RINVOQ ER 45 MG TABLET?
RINVOQ ER 45 MG TABLET (NDC 00074104328) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification